Celina joined SV in March 2025 as a team member to support the investment process of the Dementia Discovery Fund (DDF).
She also serves as a liaison between gradiant and DDF, fostering strategic partnerships and advancing collaborative initiatives.
Celina is a Principal / Manager of the Bio Working Group at gradiant, where she evaluates global investment and business development opportunities across the life sciences and healthcare sectors. Prior to joining gradiant, Celina was a Business Development Analyst / Associate Manager at SK Biopharmaceuticals.
About gradiant
gradiant is a KOSDAQ-listed company headquartered in Seoul with a mission to build a brighter future with science and innovative technology that benefits the world.
In the life sciences and healthcare sectors, gradiant has three subsidiaries—Gradiant Bioconvergence, Therapex, and AllenCare—a dietary supplement brand, Radiwell, and a nonprofit science communication organization, Knowledge Awakening On Stage (KAOS).
Formerly known as Interpark, gradiant pioneered Korea’s e-commerce industry by launching the country’s first online shopping mall and expanded its presence across diverse sectors.
Academic Credentials
Celina earned a Master of Science in Public Health (MSPH) in Health Policy & Management from the Johns Hopkins Bloomberg School of Public Health and a Bachelor of Arts in Public Health Studies from Johns Hopkins University.
